How Computational Biology is Transforming Drug R&D
Exchanges3 Maalis 2020

How Computational Biology is Transforming Drug R&D

The latest episode of Exchanges at Goldman Sachs premieres a new monthly feature: An examination of a topic at the center of conversations in the venture-capital community. This week, Goldman Sachs Research’s Heath Terry explores the growing world of computational biology—using the power of big data to revolutionize drug discovery, disease prevention and cancer detection. Terry talked to VCs like Lux Capital’s Zavain Dar, who invests in emerging science and technology firms. “It feels like we’re at the precipice of what I think will be a multi-decade revolution in how biology and chemistry are fundamentally practiced,” explains Dar. Terry also spoke with James Field, CEO of computational-biology startup LabGenius, which is using machine learning to more easily identify useful proteins for the human body. “If we can deploy technology in building out some discovery platforms in a way that the learnings compound over time,” says Field, “then it will dramatically change the economics of discovering and developing drug molecules.” Learn more about your ad choices. Visit megaphone.fm/adchoices

Jaksot(610)

Finding the Right Problems: How Sutter Hill Ventures’ Mike Speiser Creates Great Companies

Finding the Right Problems: How Sutter Hill Ventures’ Mike Speiser Creates Great Companies

As one of Silicon Valley’s most respected venture capitalists, Mike Speiser, managing director of Sutter Hill Ventures, doesn’t just invest in companies, he often takes a leading role in building them...

7 Elo 202551min

AI Exchanges: AI’s Impact on Employment

AI Exchanges: AI’s Impact on Employment

One of the biggest questions about the rise of AI is how it will impact jobs. Goldman Sachs Research’s Joseph Briggs joins GS Exchanges’ co-hosts Allison Nathan and George Lee to discuss the potentia...

5 Elo 202523min

Revenge of the Meme Stocks

Revenge of the Meme Stocks

Goldman Sachs Research's John Marshall explains the factors behind the recent rally in meme stocks, and what that resurgence means for the broader market. This episode was recorded on July 24, 2025. ...

29 Heinä 202513min

Are Investors Complacent?

Are Investors Complacent?

Markets seem to be taking tariffs and landmark changes in global trade policy in stride. Goldman Sachs’ Jan Hatzius and Dom Wilson discuss the impact of tariffs on inflation and growth, and their outl...

22 Heinä 202534min

AI Exchanges: Where Will the Power Come From?

AI Exchanges: Where Will the Power Come From?

The AI boom is creating unprecedented demand for power. So where will this power come from? Goldman Sachs' Rebecca Kruger, a partner in the Natural Resources Group in the firm's investment banking bus...

16 Heinä 202522min

The Surprising Implications of an Aging Population

The Surprising Implications of an Aging Population

An aging global population has long been viewed as a demographic time bomb. Kevin Daly, co-head of the Central and Eastern Europe, Middle East, and Africa economics team at Goldman Sachs Research, exp...

8 Heinä 202517min

Commodities Outlook: What’s Driving Oil, Gold, and Base Metals

Commodities Outlook: What’s Driving Oil, Gold, and Base Metals

Goldman Sachs’ Daan Struyven discusses how recent geopolitical events and evolving tariff policies are affecting the commodity and economic landscape. This episode was recorded on June 30, 2025. Le...

1 Heinä 202520min

Mid-year outlook: diversify and hedge

Mid-year outlook: diversify and hedge

Goldman Sachs’ Christian Mueller-Glissmann, head of asset allocation research in Goldman Sachs Research, and Alexandra Wilson-Elizondo, co-head and co-chief investment officer of the Multi-Asset Solut...

23 Kesä 202525min

Suosittua kategoriassa Liike-elämä ja talous

sijotuskasti
mimmit-sijoittaa
rss-rahapodi
psykopodiaa-podcast
herrasmieshakkerit
rss-rahamania
ostan-asuntoja-podcast
leadcast
rss-lahtijat
rss-seuraava-potilas
rss-merja-mahkan-rahat
rss-40-ajatusta-aanesta
rahapuhetta
rss-porssipuhetta
rss-vaikuttavan-opettajan-vierella
rss-bisnesta-bebeja
rss-paatos-podcast-suomen-kovimmat-paatoksentekijat-2
rss-bisneksen-pehmea-puoli
rss-levosta-kasin-yrittajyys
rss-ma